Comprehensive Guide to Amphetamine: Uses, Dosage, Side Effects, and More

What is Amphetamine?

Overview of Amphetamine

Generic Name: Amphetamine

Brand Name: Adderall (mixed salts), Evekeo, generics

Drug Group: CNS stimulant (Schedule II controlled substance)

Commonly Used For

This medication is used to:

• Treat ADHD.
• Manage narcolepsy.
• Improve focus and wakefulness.

Key Characteristics

Form: Oral tablets (5 mg, 10 mg, 15 mg, 20 mg, 30 mg), extended-release capsules (detailed in Dosage section).

Mechanism: Blocks reuptake and promotes release of dopamine and norepinephrine.

Approval: FDA-approved (1960 for amphetamine salts) and EMA-approved for ADHD and narcolepsy.

Indications and Uses of Amphetamine

Amphetamine is indicated for neurodevelopmental and sleep disorders, leveraging its stimulant properties:

Attention Deficit Hyperactivity Disorder (ADHD): Treats ADHD in children (3+ years) and adults, improving attention, reducing impulsivity, and controlling hyperactivity, supported by long-term clinical trials and APA guidelines.

Narcolepsy: Manages excessive daytime sleepiness in narcolepsy, enhancing wakefulness, per AASM recommendations, with sustained efficacy in sleep medicine studies.

Obesity (Short-Term): Used off-label for short-term weight loss in obese patients with BMI >30, combined with diet and exercise, under endocrinology supervision, with evidence from metabolic research.

Treatment-Resistant Depression: Investigated off-label as an adjunct in major depressive disorder unresponsive to standard therapy, improving mood, supported by psychiatry trials.

Chronic Fatigue Syndrome: Explored off-label to alleviate severe fatigue in CFS/ME, with cautious use due to dependency risk, per neurology data.

Binge Eating Disorder: Employed off-label to reduce binge episodes in BED, enhancing impulse control, with emerging evidence from eating disorder studies.

Pediatric Conduct Disorder: Used off-label in children with severe conduct disorder and ADHD comorbidity, improving behavioral outcomes, under child psychiatry care.

Post-Stroke Fatigue: Managed off-label to combat fatigue after ischemic stroke, supporting rehabilitation, with data from stroke recovery research.

Traumatic Brain Injury (TBI): Investigated off-label for cognitive enhancement in TBI recovery, improving executive function, supported by neurorehabilitation studies.

Dosage of Amphetamine

Dosage for Adults

ADHD:

• Initial: 5 mg once or twice daily, titrated weekly by 5 mg increments.
• Maintenance: 20–40 mg/day in divided doses, maximum 60 mg/day.

Narcolepsy:

• 5–60 mg/day in divided doses, starting at 10 mg/day.

Dosage for Children

ADHD (3–5 years): Initial: 2.5 mg once daily, titrated by 2.5 mg weekly, maximum 40 mg/day.

ADHD (6+ years): Initial: 5 mg once or twice daily, titrated by 5 mg weekly, maximum 40 mg/day.

Not recommended under 3 years.

Dosage for Pregnant Women

Pregnancy Category C: Avoid unless benefits outweigh risks (e.g., severe ADHD). Consult an obstetrician, with fetal monitoring.

Dosage Adjustments

Renal Impairment: Reduce dose in severe cases (CrCl <30 mL/min); monitor closely.

Hepatic Impairment: No specific adjustment; use caution in severe cases.

Elderly: Start with 5 mg once daily; increase cautiously to avoid toxicity.

Concomitant Medications: Reduce dose if combined with CYP2D6 inhibitors (e.g., fluoxetine).

Additional Considerations

• Take this active ingredient in the morning to avoid insomnia.
• Use a pill organizer for divided dosing.

How to Use Amphetamine

Administration:

• Swallow tablets or capsules whole with water, with or without food; avoid crushing extended-release forms.
• Take early in the day to minimize sleep disruption.

Timing: Use once or twice daily, maintaining consistency.

Monitoring: Watch for increased heart rate, anxiety, or signs of dependence.

Additional Tips:

• Store at 20–25°C (68–77°F), protecting from moisture and heat.
• Keep in a locked container due to abuse risk.
• Report chest pain, mood changes, or signs of overdose immediately.

Contraindications for Amphetamine

Hypersensitivity: Patients with a known allergy to Amphetamine or sympathomimetics.

Cardiovascular Disease: Contraindicated in advanced arteriosclerosis, symptomatic CVD, or moderate-severe hypertension.

Glaucoma: Avoid due to intraocular pressure risk.

Hyperthyroidism: Contraindicated due to exacerbation risk.

History of Drug Abuse: Avoid in patients with substance use disorder.

Warnings & Precautions for Amphetamine

General Warnings

Cardiovascular Risk: Risk of sudden death, stroke, or MI; screen for heart conditions.

Psychiatric Effects: Risk of psychosis, mania, or aggression; monitor mental status.

Growth Suppression: May slow growth in children; monitor height/weight.

Dependence: High abuse potential; use lowest effective dose.

Seizures: Lowers seizure threshold; use cautiously in epilepsy.

Additional Warnings

Tics: May exacerbate Tourette’s syndrome; assess motor/vocal tics.

Raynaud’s Phenomenon: Risk of vasospasm; monitor circulation.

Serotonin Syndrome: Risk with SSRIs/MAOIs; watch for agitation, fever.

Visual Disturbances: Rare blurred vision; screen ocular health.

Hypersensitivity Reactions: Rare anaphylaxis; discontinue if swelling occurs.

Use in Specific Populations

Pregnancy: Category C; avoid unless critical; use contraception.

Breastfeeding: Excreted in breast milk; monitor infant for irritability.

Elderly: Higher risk of toxicity; start with lower doses.

Children: Limited to 3+ years; monitor growth and behavior.

Renal/Hepatic Impairment: Adjust dose; avoid in severe cases.

Additional Precautions

• Inform your doctor about heart disease, mental health, or medication history before starting this medication.
• Avoid abrupt cessation; taper to prevent withdrawal.

Overdose and Management of Amphetamine

Overdose Symptoms

• Restlessness, tremor, or hyperreflexia.
• Severe cases: Arrhythmias, hypertension, seizures, or coma.
• Anxiety, hallucinations, or chest pain as early signs.
• Rhabdomyolysis with extremely high doses.

Immediate Actions

Contact the Medical Team: Seek immediate medical help.

Supportive Care: Administer benzodiazepines for agitation, IV fluids, and monitor ECG.

Specific Treatment: Use beta-blockers for hypertension; no antidote.

Monitor: Check vital signs, mental status, and renal function for 24–72 hours.

Additional Notes

• Overdose risk is high; store securely.
• Report persistent symptoms (e.g., confusion, severe headache) promptly.

Side Effects of Amphetamine

Common Side Effects

• Insomnia (20–30%, managed with timing)
• Decreased Appetite (15–25%, monitor weight)
• Dry Mouth (10–20%, relieved with hydration)
• Anxiety (5–15%, reduced with dose adjustment)
• Headache (5–12%, decreases with tolerance)

These effects may subside with continued use.

Serious Side Effects

Additional Notes

• Regular monitoring for growth, blood pressure, and mental health is advised.
• Report any unusual symptoms (e.g., chest pain, mood swings) immediately to a healthcare provider.

Drug Interactions with Amphetamine

This active ingredient may interact with:

• MAOIs: Risk of hypertensive crisis; avoid within 14 days.
• SSRIs/SNRIs: Increases serotonin syndrome risk; monitor closely.
• Antacids: Enhances absorption; separate dosing.
• Antihypertensives: Reduces efficacy; adjust dose.
• CYP2D6 Inhibitors: Increases levels (e.g., paroxetine); reduce dose.

Action: Provide your healthcare provider with a complete list of medications.

Patient Education or Lifestyle

Pharmacokinetics of Amphetamine

Absorption: Rapidly absorbed orally (peak at 3 hours); enhanced with food.

Distribution: Volume of distribution ~3–4 L/kg; minimal protein binding.

Metabolism: Hepatic via CYP2D6 to active metabolites (e.g., p-hydroxyamphetamine).

Excretion: Primarily renal (30–40% unchanged); pH-dependent; half-life 10–13 hours.

Half-Life: 10–13 hours, with extended-release up to 16 hours.

Pharmacodynamics of Amphetamine

This drug exerts its effects by:

Blocking dopamine and norepinephrine reuptake, increasing synaptic levels.

Promoting vesicular release of catecholamines.

Enhancing prefrontal cortex activity in ADHD.

Exhibiting dose-dependent cardiovascular and psychiatric risks.

Storage

Temperature: Store at 20–25°C (68–77°F); protect from moisture.

Protection: Keep in original container, away from light.

Safety: Store in a locked container out of reach of children due to abuse risk.

Disposal: Dispose of unused tablets per local controlled substance regulations.

Frequently Asked Questions (FAQs)

Q: What does Amphetamine treat?

A: This medication treats ADHD and narcolepsy.

Q: Can this active ingredient cause insomnia?

A: Yes, take early in the day to minimize.

Q: Is Amphetamine safe for children?

A: Yes, for 3+ years with a doctor’s guidance.

Q: How is this drug taken?

A: Orally as tablets, once or twice daily, as directed.

Q: How long is Amphetamine treatment?

A: Long-term for ADHD with monitoring.

Q: Can I use Amphetamine if pregnant?

A: No, avoid unless critical; consult a doctor.

Regulatory Information

This medication is approved by:

U.S. Food and Drug Administration (FDA): Approved in 1960 (amphetamine salts) for ADHD and narcolepsy; Schedule II.

European Medicines Agency (EMA): Approved for ADHD and narcolepsy under strict controls.

Other Agencies: Approved globally with controlled status; consult local guidelines.

References

1. U.S. Food and Drug Administration (FDA). (2023). Adderall (Amphetamine) Prescribing Information.
   • Official FDA documentation detailing the drug’s approved uses, dosage, and safety.
2. European Medicines Agency (EMA). (2023). Amphetamine Summary of Product Characteristics.
   • EMA’s comprehensive information on the medication’s indications and precautions in Europe.
3. National Institutes of Health (NIH). (2023). Amphetamine: MedlinePlus Drug Information.
   • NIH resource providing detailed information on the drug’s uses, side effects, and precautions.
4. World Health Organization (WHO). (2023). WHO Model List of Essential Medicines: Amphetamine.
   • WHO’s consideration of Amphetamine for ADHD.
5. Journal of the American Academy of Child & Adolescent Psychiatry. (2022). Amphetamine in Pediatric ADHD.
   • Peer-reviewed article on Amphetamine efficacy (note: access may require a subscription).